Intralipid Emulsion
Product Images NDC 0338-0518

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Intralipid (NDC 0338-0518). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag 10 (Bag 10)

Label for Intralipid 10%, a 10 g/100 mL intravenous fat emulsion in a 250 mL container. The product is labeled for intravenous use only and is distributed by Baxter Healthcare CORP. The NDC on the label is 0338-0518-12.*

FDA Label Image

Image 3 (Inforuse10 Image3)

An instructional diagram illustrating two types of infusion set spikes labeled as Non-vented and Vented (Closed). The image shows the structural difference between a non-vented spike and a vented spike with a closed air vent, accompanied by text instructions on using a non-vented infusion set or closing the air vent on a vented set, and guidance on spike diameter and filter pore size for infusion sets.*

FDA Label Image

Image 5 (Inforuse10 Image5)

An instructional illustration showing a hand holding the base of an infusion port while inserting a spike straight through the center of the septum by rotating the wrist. The image demonstrates proper technique for connecting the infusion spike to the port, emphasizing that the spike should be inserted straight and not at an angle. Below the illustration is a note about inspecting the bag and contents for particulate matter or discoloration before use.*

FDA Label Image

Image 2 (Infouse10 Image2)

Instructional illustration for Intralipid 10 g/100mL showing how to remove the overwrap by tearing at the notch and pulling down along the container. The diagram highlights discarding the Oxalert sachet (A) and oxygen absorber (B) before placing the bag on a clean, flat surface or hanging it on a support hook.*

FDA Label Image

Figure 1 (Instruct Fig1)

An instructional illustration showing a bag with two labeled connectors, A and B, and a related guidance note about inspecting the integrity indicator (Oxalert™) on the overwrap. It instructs that if the indicator is black, the overwrap is damaged and the product should be discarded.*

FDA Label Image

Figure 4 (Instruct Fig4)

An instructional diagram showing a person breaking off a tamper-evident arrow flag from a blue infusion port, demonstrating part of the preparation process for intravenous administration of a product.*

FDA Label Image

Figure 6 (Instruct Fig6)

An instructional illustration showing a fluid bag hanging from a hanger. The bag has two ports at the bottom connected to tubing. The diagram depicts the setup step for starting an infusion, including the hanging of the bag and connection to infusion lines.*

FDA Label Image

Fatacd (Intralipid 20 Figure 1 Fatacid Intralp)

Chemical structure diagram of the Intralipid active ingredient, showing a triglyceride molecule with carbon, oxygen, and hydrogen atoms arranged in ester bonds. The structure highlights the molecular components of the lipid emulsion.*

FDA Label Image

Phph (Intralipid 20 Figure 10 Phph Intrlp)

Chemical structure diagram depicting a triglyceride molecule, consistent with the active ingredient of Intralipid 10 g/100mL by Baxter Healthcare CORP. The structure shows a glycerol backbone with three fatty acid chains attached through ester bonds.*

FDA Label Image

Phscl (Intralipid 20 Figure 11 Phosclne Intrlp)

Chemical structure diagram of the active ingredient in Intralipid. The image displays a molecular structure with carbon, oxygen, hydrogen atoms, and functional groups, representing the composition of the ingredient.*

FDA Label Image

Phsam (Intralipid 20 Figure 12 Phosamn Intrlp)

Chemical structure diagram showing a phospholipid molecule, consistent with the active ingredient in Intralipid 10 g/100mL by Baxter Healthcare CORP. The structure includes glycerol backbone, phosphate group, and fatty acid chains represented by R and R' COOC groups.*

FDA Label Image

R1c (Intralipid 20 Figure 2 R1c Intralip)

Chemical structure diagram of the active ingredient in Intralipid 10 g/100 mL by Baxter Healthcare CORP, showing a fatty acid-related molecular structure with R1 and R2 side chains.*

FDA Label Image

R2c (Intralipid 20 Figure 3 R2c Intralip)

Chemical structure of Intralipid's active ingredient, showing a molecular arrangement with R groups and carbon, oxygen atoms, representing a lipid molecule. This diagram illustrates part of the lipid composition relevant to Intralipid 10 g/100mL.*

FDA Label Image

R3c (Intralipid 20 Figure 4 R3c Intralp)

Chemical structure of the active ingredient represented by a generic fatty acid moiety with the formula R3C=O, showing a carboxyl group with attached alkyl chains typically found in lipid molecules.*

FDA Label Image

Lnacd (Intralipid 20 Figure 5 Linacid Intralp)

Chemical structure of the active ingredient in Intralipid 10 g/100mL by Baxter Healthcare CORP, showing a triglyceride molecule typical for lipid emulsions used in parenteral nutrition.*

FDA Label Image

Oldad (Intralipid 20 Figure 6 Oleic Intrlp)

Chemical structure diagram showing the molecular formula of an active ingredient, with labeled carbon, hydrogen, and oxygen atoms. This structure is consistent with the active ingredient in Intralipid 10 g/100mL by Baxter Healthcare Corp.*

FDA Label Image

Pamad (Intralipid 20 Figure 7 Palacd Intralp)

Chemical structure diagram of Intralipid's active ingredient as presented in the product label set for Baxter Healthcare CORP. It displays a molecular formula with carbon, hydrogen, and oxygen atoms arranged in a specific configuration.*

FDA Label Image

Linad (Intralipid 20 Figure 8 2nd Linacd Intrlp)

Chemical structure diagram of the active ingredient in Intralipid 10 g/100mL by Baxter Healthcare CORP, showing the detailed molecular layout with carbon (C), hydrogen (H), and oxygen (O) atoms.*

FDA Label Image

Strad (Intralipid 20 Figure 9 Stear Intrlp)

Chemical structure diagram of Intralipid's active ingredient, depicting a fatty acid molecule with a carboxyl group and a hydrocarbon chain.*

FDA Label Image

Image 13 (Intralipid Figure 13 Intrlp)

Chemical structure of Intralipid's active ingredient as depicted in the image, showing a molecular arrangement with carbon, hydrogen, and hydroxyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.